70 likes | 199 Vues
This article delves into the ethical implications of direct-to-consumer marketing strategies for pharmaceuticals. Featuring an insightful interview with Raymond Gilmartin, former CEO of Merck, we discuss the responsibilities of companies in promoting drugs transparently while maintaining consumer safety. We also explore the FDA's regulatory role and highlight concerns about unregulated industries like herbal supplements, exemplified by companies like GNC and highlights from the "Dirty Dozen" herbs list.
E N D
Ethics March 2nd
Direct to consumer marketing of drugs • Interview with Raymond Gilmartin (Merck) • FAQ • Update
Life isn’t fair • Harrison Bergeron
The FDA • A Dirty Dozen
Herbs • A large unregulated industry • GNC • Height Max • Avacor • Herbal Watch